Secondary Analysis of a Randomized Phase 1/2 Trial of Pembrolizumab with or without Radiation Therapy for Metastatic Non-small Cell Lung Cancer

Authors :: J.Y. Chang
Chad Tang
J.W. Welsh
Q.N. Nguyen
Dawei Chen
J. Heymach
Source :: International Journal of Radiation Oncology*Biology*Physics. 108:S73
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Radiation
business.industry
medicine.medical_treatment
Pembrolizumab
medicine.disease
Radiation therapy
Secondary analysis
Internal medicine
medicine
Radiology, Nuclear Medicine and imaging
Non small cell
business
Lung cancer

Tools